Article
US Launches New Iran Strikes Overnight: 'Heavy Costs' For Attacks On Commercial Shipping
US Launches New Iran Strikes Overnight: 'Heavy Costs' For Attacks On Commercial Shipping
Summary:
US strikes on Iran announced, as 'heavy costs' for earlier targeting of multiple commercial vessels
Oil rises as Treasury revokes June 21 Iran oil waiver
Hormuz Threat Level Raised To "Severe"
Three maritime incidents reported on Hormuz in last 24 hours
Another unidentified vessel hit by a Drone
IRGC forces hit a Saudi Tanker
IRGC forces hit a Qatari LNG tanker
* * *
US Launches New Iran Strikes, In First Since Ayatollah's Funeral
The US military has announced it has commenced fresh strikes against Iran in...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Jun 25, 2026 / Kyle Anzalone
Iran Discussing Proposal With Gulf States to Establish Fees in Strait of Hormuz
Iranian officials are in negotiations with members of the Gulf Cooperation Council (GCC) about creating a system to charge fees for ships transiting the Strait of Hormuz. According to the Wall Street Journal, Iran is seeking to impose a toll on vessels entering and exiting the Persian Gulf similar to how Turkey taxes ships transiting […]
Read more
Nov 12, 2026 / Tyler Durden
Kurdish Leader Courted by Washington Urges 'Mighty US' To Make Peace With Iran
Kurdish Leader Courted by Washington Urges 'Mighty US' To Make Peace With Iran
Via Middle East EyeThe US needs to stop treating Iran as if it is governed by "mad mullahs" and engage in dialogue with the Islamic Republic, which is emerging "stronger but different" from the US-Israeli war, a senior Iraqi Kurdish official said on Thursday."Iranians are often misunderstood in the West. This notion of mad mullahs is far from the truth," Bafel Talabani said at a Strategic Forum in the Iraqi Kurdistan city of Sulaymaniyah."We don't find it difficult...
Read more
Jun 2, 2026 / Tyler Durden
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval.
Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...
Read more




